Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | HMGCR | P04035 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10966364 | 1.00 | GAA (0.51) | GAAKMT2AMEN1HMGCRHTT | |
| SCHEMBL1083078 | 0.94 | GAA (0.56) | GAAKMT2AMEN1HMGCRHTT | |
| SCHEMBL11595437 | 0.92 | GAA (0.44) | GAAKMT2AMEN1HMGCRHTT | |
| SCHEMBL858494 | 0.90 | GAA (0.60) | GAAKMT2AMEN1HMGCRHTT | |
| Ethane SCHEMBL9814026 | 0.89 | GAA (0.59) | GAAKMT2AMEN1HMGCRHTT | |
| Methane SCHEMBL5968168 | 0.89 | GAA (0.59) | GAAKMT2AMEN1HMGCRHTT | |
| SCHEMBL10786630 | 0.86 | GAA (0.56) | GAAKMT2AMEN1HMGCRHTT | |
| SCHEMBL206902 | 0.85 | GAA (0.50) | GAAKMT2AMEN1HMGCRHTT | |
| SCHEMBL28554709 | 0.85 | GAA (0.55) | GAAKMT2AMEN1HMGCRHTT | |
| SCHEMBL8399002 | 0.85 | GAA (0.55) | GAAKMT2AMEN1HMGCRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1885787-B1 | PHOSPHITE ADDITIVES IN POLYOLEFINS | PHILLIPS PETROLEUM CO (US) | 2018-01-10 | — | — | EP | claimed |
| EP-1846367-B1 | ALIPHATIC, CYCLOALIPHATIC OR (CYCLO)ALIPHATIC DIISOCYANATES THAT ARE STABLE IN STORAGE | EVONIK DEGUSSA GMBH (DE) | 2016-03-09 | — | — | EP | claimed |
| US-20120149815-A1 | Transparent Layer Forming Polymer | PROMERUS LLC (US) | 2012-06-14 | — | — | US | claimed |
| US-20100168329-A1 | ALIPHATIC, CYCLOALIPHATIC OR (CYCLO)ALIPHATIC DIISOCYANATES THAT ARE STABLE IN STORAGE | DEGUSSA GMBH (DE) | 2010-07-01 | — | — | US | claimed |
| EP-1858492-B1 | ORAL OSMOTIC DOSAGE FORM HAVING A HIGH FLUX MEMBRANE | ALZA CORP (US) | 2008-11-12 | — | — | EP | claimed |
| EP-1885787-A1 | PHOSPHITE ADDITIVES IN POLYOLEFINS | Philips Petroleum Company (US) | 2008-02-13 | — | — | EP | claimed |
| EP-1858492-A2 | ORAL OSMOTIC DOSAGE FORM HAVING A HIGH FLUX MEMBRANE | Alza Corporation (US) | 2007-11-28 | — | — | EP | claimed |
| US-7157511-B2 | Phosphite additives in polyolefins | CHEVRON PHILLIPSCHEMICAL COMPANY LP | 2007-01-02 | — | — | US | claimed |
| WO-2006124018-A1 | PHOSPHITE ADDITIVES IN POLYOLEFINS | PHILLIPS PETROLEUM COMPANY (US) | 2006-11-23 | — | — | WO | claimed |
| US-7135511-B2 | Phosphite additives in polyolefins | CHEVRON PHILLIPS CHEMICAL COMPANY, L.P. (US) | 2006-11-14 | — | — | US | claimed |
| US-4233208-A | OXIDATION RESISTANCE, RADIATION RESISTANCE | CIBA-GEIGY CORPORATION (US) | 1980-11-11 | — | — | US | claimed |
| US-4207229-A | STABILIZING POLYPROPYLENE AGAINST THERNAL, OXIDATIVE AND ULTRAVIOLET LIGHT DEGRADATION | CIBA-GEIGY CORPORATION (US) | 1980-06-10 | — | — | US | claimed |
| US-4195016-A | STABILIZERS OF POLYMERS AGAINST THERMAL, OXIDATIVE, AND ULTRAVIOLET LIGHT DEGRADATION | CIBA-GEIGY CORPORATION (US) | 1980-03-25 | — | — | US | claimed |
| US-4182704-A | STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1980-01-08 | — | — | US | claimed |
| US-4180497-A | STABILIZERS FOR ORGANIC POLYMERS AGAINST THERMAL, OXIDATIVE AND UV LIGHT DEGRADATION | CIBA-GEIGY CORPORATION (US) | 1979-12-25 | — | — | US | claimed |
| US-4147645-A | STERICALLY HINDERED PHENOL STABILIZER ADDITIVE FOR RESIN | XEROX CORPORATION (US) | 1979-04-03 | — | — | US | claimed |
| US-4117178-A | PHENOLIC ANTIOXIDANTS FOR NON-POLYMERIC HALOGEN COMPOUNDS DURING IMPREGNATION OF STYRENE POLYMER PARTICLES | ARCO POLYMERS, INC. (US) | 1978-09-26 | — | — | US | claimed |
| US-4101326-A | Process for making stabilized polyesters used in radiation-sensitive compositions for lithographic plates having improved wear life including hindered phenols and phosphoric acid esters | EASTMAN KODAK COMPANY (US) | 1978-07-18 | — | — | US | claimed |
| US-3935164-A | NICKEL 3,5-DI-TERT-ALKYL 4-HYDROXYBENZOATE, AND A BENZOPHENONE OR BENZOTRIAZOLE | CIBA-GEIGY CORPORATION (US) | 1976-01-27 | — | — | US | claimed |
| US-3933736-A | HOMO- AND CO-POLYMERS OF ETHYLENE, PROPYLENE, BUTENE-1, PENTENE-1, AND 4-METHYLPENTENE-1 WITH ETHYL ACRYLATE OR VINYL ACETATE | UBE INDUSTRIES, LTD. (JA) | 1976-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168329-A1 | ALIPHATIC, CYCLOALIPHATIC OR (CYCLO)ALIPHATIC DIISOCYANATES THAT ARE STABLE IN STORAGE | DDT, AADAC, SCD | GAA 405/4885KMT2A 2933/4885MEN1 2047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.